Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and fish oil for prevention of early thrombosis in arteriovenous fistulae in haemodialysis patients
2009-014868-19Phase 3Unknown
- Sponsor
- Australasian Kidney Trials Network
- Start
- Aug 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of omega-3-acid triglycerides, aspirin and doconexent ethyl in chronic kidney disease (CKD), arteriovenous fistula thrombosis (AVFT) and thrombosis (4 arms), sponsored by Australasian Kidney Trials Network. Status: unknown.
02
Drugs
omega-3-acid triglyceridesaspirindoconexent ethyl
03
Conditions
chronic kidney disease (CKD)arteriovenous fistula thrombosis (AVFT)thrombosis
Beyond the preview
Go deeper on 2009-014868-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014868-19.